The verdict was announced on April 26, following a 5-day trial by jury. According to a press release from Sight Sciences, the ...

Rick Lewis, chief medical officer of ViaLase, describes the company's nonincisional glaucoma treatment, showing promising ...

The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, ...

Joseph Izatt was a skilled researcher and inventor who played a foundational role in the development of optical coherence ...

Researchers found the model demonstrated “near-perfect” detection capabilities. A recent study conducted by US and Australian ...

David Hutton, Managing Editor of Ophthalmology Times sat down with Claris Bio CEO, Clarke Atwell, to discuss the company's ...

George O. Waring IV, MD, FACS, highlighted preliminary data from an open-label clinical trial, where his site was 1 of 4 in ...

Neda Nikpoor, MD, urges audience members to become more empowered in making small but meaningful, evidence-based changes in ...

The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting ...

Deborah Gess Ristvedt, DO, shares highlights from her presentation and what these real-world cases mean for clinicians and ...

A brief analysis showed that ChatGPT 3.5 performed better. With an increase in artificial intelligence being used in everyday ...

Program cochair Arjan Hura, MD, previews this year’s extended schedule with discussions on retina gene therapies, corneal ...